FisclearFisclear

Financial Comparison

Divi's Laboratories Limited vs Torrent Pharmaceuticals Limited

Click a ticker to view the full analysis.

DIVISLAB.NS vs

In short

Divi's Laboratories Limited is the more profitable of the two, keeping 24.5% of revenue as net profit against 15.7% for Torrent Pharmaceuticals Limited. Divi's Laboratories Limited trades at the higher trailing P/E (85.0× vs 72.5× for Torrent Pharmaceuticals Limited), so investors pay more for each dollar of its earnings. Fisclear flags 1 medium- or high-severity risk for Divi's Laboratories Limited and 1 for Torrent Pharmaceuticals Limited.

Based on filings for periods ending 31 Mar 2026 (DIVISLAB.NS) and 31 Mar 2026 (TORNTPHARM.NS) · Updated

FisclearScore Comparison

DIVISLAB.NS55Fair
TORNTPHARM.NS66Strong
Quality+9
83
74
Efficiency+2
62
60
Value+26
26
52
Cashflow+37
39
76
Regime
55
55
Peers+18
58
76

FisclearScore is a quantitative model. DIVISLAB.NS shown solid · TORNTPHARM.NS shown dashed. Not financial advice.

MetricDIVISLAB.NSTORNTPHARM.NS
Price₹9,363.50₹4,632.70
Market Cap₹2.49T₹1.76T
P/E (TTM)85.0x72.5x
P/B14.8x18.7x
Beta0.230.14
Div Yield0.32%0.81%
Revenue (TTM)₹104.8B₹137.5B
Net Income₹25.7B₹21.6B
Gross Margin59.1%74.4%
Risk Flags1 flag1 flag
Full DIVISLAB.NS Report →Full TORNTPHARM.NS Report →

Related comparisons

DIVISLAB.NS vs Sun PharmaceuticalSun Pharmaceutical vs TORNTPHARM.NSDIVISLAB.NS vs Dr. Reddy's LaboratoriesDr. Reddy's Laboratories vs TORNTPHARM.NSCIPLA.NS vs DIVISLAB.NSCIPLA.NS vs TORNTPHARM.NS

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.